Since the outbreak of the novel coronavirus disease (COVID-19), the therapeutic and management options to reduce the burden of the COVID-19 disease are under investigation. IVIG therapy is used as an effective treatment for immunodeficient patients and patients with inflammatory or autoimmune conditions. The therapeutic effect of IVIG in COVID-19 patients has been investigated. But, the results are controversial and some studies reported no benefit of IVIG therapy. More clinical trials on the effect of IVIG therapy in COVID-19 patients should be performed to establish a certain conclusion about IVIG effectiveness.
All Keywords
【저자키워드】 Treatment, coronavirus disease, Intravenous immunoglobulin, Respiratory syndromes, Hyperreactivity, 【초록키워드】 COVID-19, clinical trial, therapy, novel coronavirus disease, COVID-19 disease, outbreak, management, therapeutic, Patient, Effectiveness, Inflammatory, COVID-19 patient, therapeutic effect, autoimmune conditions, effective, benefit, performed, reported, investigated, reduce, immunodeficient patient, 【제목키워드】 COVID-19, Therapeutic approach, Potential,
【저자키워드】 Treatment, coronavirus disease, Intravenous immunoglobulin, Respiratory syndromes, Hyperreactivity, 【초록키워드】 COVID-19, clinical trial, therapy, novel coronavirus disease, COVID-19 disease, outbreak, management, therapeutic, Patient, Effectiveness, Inflammatory, COVID-19 patient, therapeutic effect, autoimmune conditions, effective, benefit, performed, reported, investigated, reduce, immunodeficient patient, 【제목키워드】 COVID-19, Therapeutic approach, Potential,